| Literature DB >> 29361523 |
Qi Sun1, Jiao Miao1, Jing Luo1, Qi Yuan1, Hongdi Cao1, Weifang Su1, Yang Zhou1, Lei Jiang1, Li Fang1, Chunsun Dai2, Ke Zen3, Junwei Yang2.
Abstract
Renal fibrosis is a final common pathway of chronic kidney disease. Sustained activation of fibroblasts is considered to play a key role in perpetuating renal fibrosis but the driving force in the perpetuation stage is only partially understood. To date, some investigations have specifically identified overexpression of microRNA 21 (miR-21) in the progression of kidney fibrosis. Nevertheless, the precise role of miR-21 in fibroblast activation remains largely unknown. In this study, we found that miR-21 was significantly upregulated in activated fibroblasts and that it maintained itself at constant high levels by employing an auto-regulatory loop between miR-21, PDCD4 and AP-1. Persistently upregulated miR-21 suppressed protein expression of Smad7 and, eventually, enhanced the TGF-β1/Smad pathway to promote fibroblast activation. More importantly, we found miR-21 sequestration with miR-21 antagomir or AP-1 inhibitors attenuated unilateral ureteral obstruction (UUO)-induced renal fibrosis. miR-21-knockout mice also suffered far less interstitial fibrosis in response to kidney injury. Altogether, these data suggest that miR-21 is a main driving force of fibroblast activation and keeps its high expression level by employing a double negative autoregulatory loop. Targeting this aberrantly activated feedback loop may provide new therapeutic strategy in treating fibrotic kidneys.Entities:
Keywords: Fibroblasts; MicroRNA; Renal fibrosis; miR-21; miR-21/PDCD4/AP-1
Mesh:
Substances:
Year: 2018 PMID: 29361523 DOI: 10.1242/jcs.202317
Source DB: PubMed Journal: J Cell Sci ISSN: 0021-9533 Impact factor: 5.285